is semaglutide only injectable Tirzepatide vs. Semaglutide: What You Should Know Semaglutide Dosage Chart Units: How

The math sets you free to dose with precision

Semaglutide, ook bekend als de werkzame stof in Ozempic en Rybelsus, is een medicijn dat wordt gebruikt voor de behandeling van type 2 diabetes en obesitas

Dexcoms revenue has grown significantly from $1.0 billion in 2018 to $3.6 billion in 2023, or a 29% CAGR

A few years ago, only endocrinologists and obesity specialists were talking about GLP-1 medications like Ozempic and Wegovy

The question that arises is no longer, "Does it work? But, "Who owns the next generation mechanism? Were likely entering a phase where: Large-cap pharma consolidates metabolic platforms Mid-cap biotech becomes an acquisition target (mechanism-driven) Valuations increasingly reflect mechanism optionality, not single indications And importantly: The winners may not be the first GLP-1 players But those building next-gen metabolic architectures Bottom line: If GLP-1 were the opening trade, multi-pathway metabolic drugs may represent the full cycle

Provider involvement